相关产品推荐更多 >

KRTAP3-1抗体KRTAP3-1兔多抗抗体Keratin-associated protein 3.1 antibody抗体KRTAP3-1 Antibody抗体
¥440
THTPA抗体THTPA兔多抗抗体EC 3.6.1.28 antibody抗体THTPA Antibody, Biotin conjugated抗体
¥880
PPFIA1抗体PPFIA1兔多抗抗体PTPRF-interacting protein alpha-1 antibody抗体PPFIA1 Antibody抗体
¥440
TRAF3IP3抗体TRAF3IP3一抗抗体TRAF3-interacting protein 3 antibody抗体TRAF3IP3 Antibody抗体
¥880
Map2k4抗体Map2k4兔多抗抗体SEK1 antibody抗体Map2k4 Antibody, HRP conjugated抗体
¥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Human ELMO domain-containing protein 3 protein (1-102AA)
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性:
Polyclonal
- 标记物:
FITC
- 适应物种:
Human
- 保质期:
6个月
- 抗原来源:
Homo sapiens (Human)
- 目录编号:
Q96FG2
- 级别:
优
- 库存:
200
- 供应商:
武汉华美生物工程有限公司
- 宿主:
Rabbit
- 应用范围:
/
- 浓度:
>95%,Protein G purified
- 靶点:
ELMOD3
- 抗体英文名:
ELMOD3 Antibody, FITC conjugated
- 抗体名:
ELMOD3 antibody;RBED1 antibody;RBM29 antibody;PP4068ELMO domain-containing protein 3 antibody;RNA-binding motif and ELMO domain-containing protein 1 antibody;RNA-binding motif protein 29 antibody;RNA-binding protein 29 antibody
- 规格:
100μg/50μg
| 规格: | 100μg | 产品价格: | ¥1320.0 |
|---|---|---|---|
| 规格: | 50μg | 产品价格: | ¥880.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
功能
Acts as a GTPase-activating protein (GAP) for ARL2 with low specific activity.风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验RUVKUN Antibody Staining Protocol revised 10/29/90
RUVKUN Antibody Staining Protocol revised 10/29/90 Fixation: 1. C. elegans N2 grown in liquid or plates. Harvest worms. Wash for 2 hours at room temp. in 1X M9 or PBS. 2. Fix in 5 ml of FRESH THAT DAY 1% paraformaldehyde:
secondary antibody review -- data from 99 publications
cytometry used as a control to detect cell responses targeted antigen 7 Alexa Fluor 488 7 Cy3 8 goat IgG Alexa Fluor 488 1:2000 detect antibody binding in human embryonic kidney 293T cells Invitrogen 9 donkey
中科院高福院士课题组 2020 年发表了哪些重要的研究成果?
:Science 9、Science 后再发 Nature!筛选出又一新冠病毒治疗性单克隆中和抗体DOI: 10.1038/s41586-020-2381-y继之前发表在 Science 上报道筛选出新冠病毒中和抗体后,2020 年 5 月 26 日,高福院士再次联合严景华等人在 Nature 发文:A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2。该研究报告了从 COVID-19 恢复期的患者中分离出两
技术资料暂无技术资料 索取技术资料





